证券代码：000985 证券简称：大庆华科 公告编号：2025006 大庆华科股份有限公司 关于 2024 年度利润分配预案的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没 有虚假记载、误导性陈述或者重大遗漏。 一、审议程序 大庆华科股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日召开第九届董事会独立董事专门会议 2025 年第一次会议、第九届 董事会第四次会议、第九届监事会第四次会议，会议审议通过了 《关于 2024 年度利润分配预案的议案》，该议案尚需提交公司 2024 年年度股东大会审议。 二、利润分配和资本公积金转增股本方案的基本情况 1、本次利润分配为公司 2024 年度利润分配。 2、经天健会计师事务所（特殊普通合伙人）审计，公司 2024 年度净利润为 1,479.54 万元，根据《公司法》《公司章程》等相关 法律法规的规定，公司本期提取法定盈余公积金 147.95 万元，截止 2024 年 12 月 31 日公司可供股东分配利润 12,021.86 万元，总股本 为 12,963.95 万股。 3、公司以 2024 年 12 月 31 日总股本 12,963.9 ...

前十大流通股东累计持有： 8830.65万股，累计占流通股比： 68.12%，较上期变化： -244.17万股。 | 名称 持有数量(万股) | | 占总股本比例 | 增减情况(万 | | --- | --- | --- | --- | | | | (%) | 股) | | 中国石油大庆石油化工有限公司 | 7133.97 | 55.03 | 不变 | | 大庆高新国有资产运营有限公司 | 1098.09 | 8.47 | 不变 | | 全国社保基金六零四组合 | 145.75 | 1.12 | 新进 | | 李永良 | 83.74 | 0.65 | 新进 | | 王琼 | 74.57 | 0.58 | 新进 | | 周顺东 | 66.50 | 0.51 | -34.08 | | 张彪 | 64.14 | 0.49 | 新进 | | 磐厚动量(上海)资本管理有限公司-磐厚动量-旅行者2 | | | | | 号私募基金 | 58.37 | 0.45 | 新进 | | 侯盾 | 55.52 | 0.43 | -146.14 | | 荣海翠 | 50.00 | 0.39 | 新进 | | 较上个报告期退出前十大股东 ...

目 录 大庆华科股份有限公司全体股东： 一、审计意见 我们审计了大庆华科股份有限公司（以下简称大庆华科公司）财务报表，包 括 2024 年 12 月 31 日的资产负债表，2024 年度的利润表、现金流量表、所有者 权益变动表，以及相关财务报表附注。 我们认为，后附的财务报表在所有重大方面按照企业会计准则的规定编制， 公允反映了大庆华科公司 2024 年 12 月 31 日的财务状况，以及 2024 年度的经营 成果和现金流量。 二、形成审计意见的基础 我们按照中国注册会计师审计准则的规定执行了审计工作。审计报告的"注 册会计师对财务报表审计的责任"部分进一步阐述了我们在这些准则下的责任。 按照中国注册会计师职业道德守则，我们独立于大庆华科公司，并履行了职业道 德方面的其他责任。我们相信，我们获取的审计证据是充分、适当的，为发表审 计意见提供了基础。 三、关键审计事项 关键审计事项是我们根据职业判断，认为对本期财务报表审计最为重要的事 项。这些事项的应对以对财务报表整体进行审计并形成审计意见为背景，我们不 对这些事项单独发表意见。 | 一、审计报告……………………………………………………… | 第 | 1—5 ...

目 录 | 一、内部控制审计报告…………………………………………第 | | --- | | 1—2 页 | 二、附件…………………………………………………………第 3—6 页 内部控制审计报告 天健审〔2025〕7554 号 大庆华科股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求，我 们审计了大庆华科股份有限公司（以下简称大庆华科公司）2024 年 12 月 31 日 的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》《企业内部控制应用指引》以及《企业内部 控制评价指引》的规定，建立健全和有效实施内部控制，并评价其有效性是大庆 华科公司董事会的责任。 二、注册会计师的责任 我们认为，大庆华科公司于 2024 年 12 月 31 日按照《企业内部控制基本规 第 1 页 共 6 页 范》和相关规定在所有重大方面保持了有效的财务报告内部控制。 天健会计师事务所（特殊普通合伙） 中国注册会计师： 中国·杭州 中国注册会计师： 二〇二五年四月二十四日 第 2 页 共 6 页 我们的责任是在实施审计工作的基础上，对财务报告内部控制的有效性发表 审计 ...

目 录 一、非经营性资金占用及其他关联资金往来情况的专项 审计说明…………………………………………………………第 1—2 页 二、非经营性资金占用及其他关联资金往来情况汇总表…………… 第 3 页 三、附件…………………………………………………………………第 4-7 页 非经营性资金占用及其他关联资金往来情况的 专项审计说明 天健审〔2025〕7684 号 大庆华科股份有限公司全体股东： 我们接受委托，审计了大庆华科股份有限公司（以下简称大庆华科公司）2024 年度财务报表，包括 2024 年 12 月 31 日的资产负债表，2024 年度的利润表、现 金流量表、所有者权益变动表，以及财务报表附注，并出具了审计报告。在此基 础上，我们审计了后附的大庆华科公司管理层编制的 2024 年度《非经营性资金 占用及其他关联资金往来情况汇总表》（以下简称汇总表）。 一、对报告使用者和使用目的的限定 本报告仅供大庆华科公司年度报告披露时使用，不得用作任何其他目的。我 们同意将本报告作为大庆华科公司年度报告的必备文件，随同其他文件一起报送 并对外披露。 为了更好地理解大庆华科公司 2024 年度非经营性资金占用及其他关联资 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥501,980,817.11, representing a 3.97% increase compared to ¥482,819,586.36 in the same period last year[3] - Net profit attributable to shareholders for Q1 2025 was ¥7,127,128.56, a significant increase of 93.95% from ¥3,674,785.42 in the previous year[3] - The net profit after deducting non-recurring gains and losses was ¥6,583,740.67, up 34.94% from ¥4,878,906.14 year-on-year[3] - Basic and diluted earnings per share for Q1 2025 were both ¥0.055, reflecting a 96.43% increase from ¥0.028 in the previous year[3] - Total operating revenue for the current period reached ¥501,980,817.11, an increase of 3.9% compared to ¥482,819,586.36 in the previous period[12] - Net profit for the current period was ¥7,127,128.56, representing a significant increase of 94.5% from ¥3,674,785.42 in the previous period[12] - The total comprehensive income attributable to the parent company reached CNY 7,127,128.56, compared to CNY 3,674,785.42 in the previous period, indicating a significant increase[13] - Basic and diluted earnings per share both improved to CNY 0.055 from CNY 0.028 year-over-year[13] Cash Flow - The net cash flow from operating activities increased by 30.18% to ¥41,161,748.29, compared to ¥31,620,128.89 in the same quarter last year[3] - Net cash flow from operating activities was CNY 41,161,748.29, up from CNY 31,620,128.89 in the previous period, reflecting a growth of approximately 30.5%[13] - Cash inflow from operating activities totaled CNY 620,737,007.22, slightly increasing from CNY 609,995,258.38[13] - Cash outflow from operating activities was CNY 579,575,258.93, compared to CNY 578,375,129.49 in the previous period, showing a marginal increase[14] - The net cash flow from investing activities was negative at CNY -24,372,680.64, worsening from CNY -6,450,969.28 in the previous period[14] - The net increase in cash and cash equivalents was CNY 16,789,067.65, down from CNY 25,169,159.61 in the previous period[14] - The ending balance of cash and cash equivalents stood at CNY 344,985,129.49, compared to CNY 336,208,944.19 at the end of the previous period[14] - The company did not report any investment income during the current period, contrasting with CNY 63,787.50 in the previous period[14] Assets and Liabilities - Total assets at the end of Q1 2025 were ¥694,661,424.67, a slight decrease of 0.36% from ¥697,155,250.75 at the end of the previous year[3] - Total liabilities decreased to ¥81,565,796.23 from ¥93,102,602.50, a reduction of 12.4%[11] - Current assets totaled ¥400,882,032.44, showing a slight increase from ¥394,602,398.65, an increase of 1.3%[10] - Non-current assets decreased to ¥293,779,392.23 from ¥302,552,852.10, a decline of 2.6%[10] - The company’s retained earnings increased to ¥127,345,773.97 from ¥120,218,645.41, a growth of 5.3%[11] Shareholder Information - The total number of common shareholders at the end of the reporting period was 8,613, with the largest shareholder, China Petroleum Daqing, holding 55.03% of the shares[6] - Shareholders' equity attributable to the parent company increased by 1.50% to ¥613,095,628.44 from ¥604,052,648.25 at the end of the previous year[3] Government Subsidies and Expenses - The company received government subsidies amounting to ¥655,732.44 during the reporting period, which are closely related to its normal business operations[4] - Total operating costs amounted to ¥492,511,772.44, up from ¥476,493,010.31, reflecting a rise of 3.4%[12] - The company reported a financial expense of -¥874,441.14, an improvement compared to -¥2,126,238.83 in the previous period[12] - Research and development expenses were ¥419,800.44, indicating investment in innovation[12] Other Information - The company does not have any significant changes in its non-recurring gains and losses items during the reporting period[5] - The company’s first quarter report for 2024 is unaudited, and the new accounting standards will be implemented starting in 2024[14]

Dividend and Shareholder Information - The company plans to distribute a cash dividend of 0.5 RMB per 10 shares to all shareholders, based on a total of 129,639,500 shares[3]. - The largest shareholder, China Petroleum Daqing Oilfield Company, holds 55.03% of the total shares, amounting to 71,339,700 shares[132]. - Daqing High-tech State-owned Assets Operation Company holds 8.47% of the shares, totaling 10,980,900 shares, with 5,490,000 shares pledged[132]. - The company proposed a cash dividend of ¥0.50 per 10 shares, amounting to a total cash dividend of ¥6,481,975.00, which is 100% of the profit distribution[96][97]. - The company reported a net profit of ¥14,795,400.00 for the period, with a distributable profit of ¥120,218,645.41[97]. Financial Performance - The company's operating revenue for 2024 was approximately ¥1.97 billion, a decrease of 1.54% compared to ¥2.00 billion in 2023[14]. - Net profit attributable to shareholders increased by 160.63% to approximately ¥14.80 million in 2024, up from ¥5.68 million in 2023[14]. - The net profit after deducting non-recurring gains and losses surged by 1,388.69% to approximately ¥15.48 million in 2024, compared to ¥1.04 million in 2023[14]. - Basic earnings per share rose by 160.50% to ¥0.1141 in 2024, compared to ¥0.0438 in 2023[14]. - Total assets at the end of 2024 were approximately ¥697.16 million, a decrease of 0.68% from ¥701.94 million at the end of 2023[15]. - Net assets attributable to shareholders increased by 3.07% to approximately ¥604.05 million at the end of 2024, compared to ¥586.06 million at the end of 2023[15]. Production and Capacity - The company reported a significant increase in the production capacity of C5 resources, reaching 4.5 million tons by the end of 2024, with a compound annual growth rate of 10.9%[22]. - The company's polypropylene production capacity has increased from 30,000 tons per year to 110,000 tons per year after three expansions[30]. - The company has a production capacity utilization rate of 97.02% for polypropylene and 100% for C9 series products[33]. - The sales volume in the chemical industry increased by 19.59% to 465,117.30 tons in 2024, up from 388,932.79 tons in 2023[47]. Research and Development - Research and development expenses decreased by 90.50% to ¥954,415.11, primarily due to a reduction in dedicated R&D personnel[52]. - The number of R&D personnel dropped by 89.66% from 58 in 2023 to 6 in 2024, significantly impacting the company's R&D capacity[53]. - The company has obtained a total of 16 national patents, including 11 invention patents, for its core technologies in C5 and C9 petroleum resins[38]. Environmental and Safety Compliance - The company reported a 100% compliance rate in safety and environmental monitoring during the reporting period[41]. - The company achieved a 100% compliance rate for the disposal of waste gas, waste water, and solid waste during the reporting period[107]. - The company has no records of environmental complaints, violations, or penalties during the reporting period[113]. - The company invested a total of 6.7172 million yuan in environmental governance and protection during the reporting period[111]. Governance and Management - The company maintains a fully independent operational structure, ensuring separation from its controlling shareholder in all aspects[68]. - The company is committed to maintaining stability in its leadership, with all current directors and supervisors serving until at least September 2026[73]. - The company has established a compensation and assessment committee responsible for evaluating senior management and determining their remuneration[83]. - The total number of employees at the end of the reporting period is 450, with 309 in production, 10 in sales, 86 in technology, 10 in finance, and 35 in administration[92]. Related Party Transactions - The total amount of related party transactions for the company reached 241,780.57 million CNY, with 99.83% of transactions priced at market rates[122]. - The company engaged in procurement transactions with Daqing Petrochemical, amounting to 199,215.31 million CNY, representing 93.27% of similar transaction amounts[121]. - The company accepted labor services from Daqing Petrochemical Construction, totaling 3,048.88 million CNY, which exceeded the approved transaction limit by 30.99%[121]. Audit and Financial Reporting - The audit report issued by Tianjian Accounting Firm confirmed that the financial statements fairly reflect the company's financial position as of December 31, 2024[144]. - The audit identified revenue recognition as a key audit matter due to the inherent risks associated with management's potential inappropriate revenue recognition practices[146]. - Management is responsible for preparing financial statements in accordance with accounting standards and ensuring the absence of material misstatements due to fraud or error[151]. Future Outlook and Strategy - The company anticipates stable growth in the chemical products market, despite challenges from geopolitical tensions and trade policy uncertainties[21]. - The focus will be on technological innovation and the development of high-value products in the new energy and new materials sectors[64]. - The company plans to enhance its governance structure and management efficiency to achieve high-quality sustainable development[63].

大庆华科股份有限公司 市值管理制度 第一章 总则 第一条 为切实推动大庆华科股份有限公司（以下简称"公司"） 提升投资价值，增强投资者回报，加强公司市值管理，维护公司、投 资者及其他利益相关方的合法权益，根据《中华人民共和国公司法》 《中华人民共和国证券法》《上市公司信息披露管理办法》《上市公司 监管指引第 10 号——市值管理》等法律法规、规范性文件及《大庆 华科股份有限公司章程》（以下简称《公司章程》）的规定，结合公司 实际情况，制定本制度。 第二条 本制度所称市值管理，是指以提高公司质量为基础，为 提升公司投资价值和股东回报能力而实施的战略管理行为。 第三条 公司应当牢固树立回报股东意识，采取措施保护投资者 尤其是中小投资者利益，诚实守信、规范运作、专注主业、稳健经营， 以新质生产力的培育和运用，推动经营水平和发展质量提升，并在此 基础上做好投资者关系管理，增强信息披露质量和透明度，必要时积 极采取措施提振投资者信心，推动公司投资价值合理反映公司质量。 第四条 公司应当积极做好与股东的沟通，引导股东长期投资。 第二章 市值管理的目的与基本原则 第五条 市值管理的主要目的是通过制定正确发展战略、完善公 司 ...

王涌：1966年8月出生，中国国籍，无境外永久居留权， 研究生学历，副教授。历任哈尔滨科技大学教师，哈尔滨 理工大学教师、副主任，哈尔滨理工大学经济与管理学院 会计系主任。现任哈尔滨理工大学经济与管理学院教师。 2020 年 5 月起任公司独立董事。 2、独立性情况说明 作为公司的独立董事，未在公司担任除独立董事以外 的任何职务，本人及直系亲属、主要社会关系均未在公司 任职，亦不存在为公司及控股股东或者其附属企业提供财 务、法律、咨询等服务的情形，不存在妨碍本人进行独立 客观判断的情形，亦不存在违反《上市公司独立董事管理办 法》第六条规定的独立董事任职独立性要求的情形。 大庆华科股份有限公司 2024 年度独立董事述职报告 （王涌） 本人王涌，作为大庆华科股份有限公司（以下简称"公 司"）独立董事，严格按照《公司法》《证券法》《上市公司治 理准则》《上市公司独立董事管理办法》《深圳证券交易所上 市公司自律监管指引第 1 号—主板上市公司规范运作》等有 关法律法规和《公司章程》《独立董事工作制度》等相关规定， 本着恪尽职守、勤勉尽责的工作态度，积极出席公司股东 大会、董事会及各专门委员会，认真审议董事会各项议案 ...

根据中国证券监督管理委员会《上市公司独立董事管理办法》《深圳 证券交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第1 号——主板上市公司规范运作》等要求，大庆华科股份有限公司（以下简 称"公司"）董事会，就公司在任独立董事王涌先生、李国峰先生、赵云 宝先生、潘明先生的独立性情况进行评估并出具如下专项意见： 经核查独立董事王涌先生、李国峰先生、赵云宝先生、潘明先生的任 职经历以及签署的相关自查文件，上述人员及直系亲属、主要社会关系均 未在公司担任除独立董事以外的任何职务，也未在公司主要股东公司担任 任何职务；不存在为公司及控股股东或者其附属企业提供财务、法律、咨 询等服务的情形；与公司以及主要股东之间不存在利害关系或其他可能妨 碍其进行独立客观判断的关系，不存在影响独立董事独立性的情况。符合 《上市公司独立董事管理办法》《深圳证券交易所上市公司自律监管指引 第1号——主板上市公司规范运作》中对独立董事独立性的相关要求。 大庆华科股份有限公司 董事会对独立董事独立性评估的专项意见 大庆华科股份有限公司董事会 2025年4月24日 ...